NM_001101648.2:c.816C>G

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1

The NM_001101648.2(NPC1L1):​c.816C>G​(p.Leu272Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.233 in 1,613,858 control chromosomes in the GnomAD database, including 45,308 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.24 ( 4483 hom., cov: 33)
Exomes 𝑓: 0.23 ( 40825 hom. )

Consequence

NPC1L1
NM_001101648.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1O:1

Conservation

PhyloP100: 1.15

Publications

120 publications found
Variant links:
Genes affected
NPC1L1 (HGNC:7898): (NPC1 like intracellular cholesterol transporter 1) The protein encoded by this gene is a multi-pass membrane protein. It contains a conserved N-terminal Niemann-Pick C1 (NPC1) domain and a putative sterol-sensing domain (SSD) which includes a YQRL motif functioning as a plasma membrane to trans-Golgi network transport signal in other proteins. This protein takes up free cholesterol into cells through vesicular endocytosis and plays a critical role in the absorption of intestinal cholesterol. It also has the ability to transport alpha-tocopherol (vitamin E). The drug ezetimibe targets this protein and inhibits the absorption of intestinal cholesterol and alpha-tocopherol. In addition, this protein may play a critical role in regulating lipid metabolism. Polymorphic variations in this gene are associated with plasma total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels and coronary heart disease (CHD) risk. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 7-44539581-G-C is Benign according to our data. Variant chr7-44539581-G-C is described in ClinVar as Benign. ClinVar VariationId is 403258.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.15 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.361 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001101648.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPC1L1
NM_001101648.2
MANE Select
c.816C>Gp.Leu272Leu
synonymous
Exon 2 of 19NP_001095118.1
NPC1L1
NM_013389.3
c.816C>Gp.Leu272Leu
synonymous
Exon 2 of 20NP_037521.2
NPC1L1
NM_001300967.2
c.816C>Gp.Leu272Leu
synonymous
Exon 2 of 7NP_001287896.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NPC1L1
ENST00000381160.8
TSL:1 MANE Select
c.816C>Gp.Leu272Leu
synonymous
Exon 2 of 19ENSP00000370552.3
NPC1L1
ENST00000289547.8
TSL:1
c.816C>Gp.Leu272Leu
synonymous
Exon 2 of 20ENSP00000289547.4
NPC1L1
ENST00000546276.5
TSL:1
c.816C>Gp.Leu272Leu
synonymous
Exon 2 of 18ENSP00000438033.1

Frequencies

GnomAD3 genomes
AF:
0.236
AC:
35859
AN:
152028
Hom.:
4472
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.206
Gnomad AMI
AF:
0.114
Gnomad AMR
AF:
0.227
Gnomad ASJ
AF:
0.221
Gnomad EAS
AF:
0.375
Gnomad SAS
AF:
0.214
Gnomad FIN
AF:
0.368
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.230
Gnomad OTH
AF:
0.206
GnomAD2 exomes
AF:
0.249
AC:
62483
AN:
250938
AF XY:
0.245
show subpopulations
Gnomad AFR exome
AF:
0.209
Gnomad AMR exome
AF:
0.254
Gnomad ASJ exome
AF:
0.204
Gnomad EAS exome
AF:
0.364
Gnomad FIN exome
AF:
0.369
Gnomad NFE exome
AF:
0.228
Gnomad OTH exome
AF:
0.231
GnomAD4 exome
AF:
0.232
AC:
339457
AN:
1461712
Hom.:
40825
Cov.:
40
AF XY:
0.231
AC XY:
168147
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.212
AC:
7086
AN:
33480
American (AMR)
AF:
0.249
AC:
11148
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.211
AC:
5520
AN:
26132
East Asian (EAS)
AF:
0.374
AC:
14847
AN:
39700
South Asian (SAS)
AF:
0.206
AC:
17743
AN:
86252
European-Finnish (FIN)
AF:
0.359
AC:
19138
AN:
53270
Middle Eastern (MID)
AF:
0.166
AC:
960
AN:
5768
European-Non Finnish (NFE)
AF:
0.224
AC:
248981
AN:
1112000
Other (OTH)
AF:
0.232
AC:
14034
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
17983
35966
53948
71931
89914
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8670
17340
26010
34680
43350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.236
AC:
35902
AN:
152146
Hom.:
4483
Cov.:
33
AF XY:
0.244
AC XY:
18129
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.206
AC:
8567
AN:
41522
American (AMR)
AF:
0.228
AC:
3487
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.221
AC:
767
AN:
3468
East Asian (EAS)
AF:
0.375
AC:
1939
AN:
5174
South Asian (SAS)
AF:
0.214
AC:
1032
AN:
4818
European-Finnish (FIN)
AF:
0.368
AC:
3901
AN:
10588
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.230
AC:
15610
AN:
67958
Other (OTH)
AF:
0.211
AC:
446
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1420
2840
4261
5681
7101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
380
760
1140
1520
1900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.231
Hom.:
3184
Bravo
AF:
0.225
Asia WGS
AF:
0.298
AC:
1035
AN:
3478
EpiCase
AF:
0.214
EpiControl
AF:
0.219

ClinVar

Significance: Benign
Submissions summary: Benign:1Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Statins, attenuated cholesterol lowering by Other:1
Nov 01, 2022
Department of Cardiology, Chinese Academy of Medical Sciences, Fuwai Hospital
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:research

likely responsive

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.5
DANN
Benign
0.43
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2072183; hg19: chr7-44579180; COSMIC: COSV56923068; API